Analysis of peptide-protein binding using amino acid descriptors: Prediction and experimental verification for human histocompatibility complex HLA-A*0201

Journal of Medicinal Chemistry

Volumn 48, Issue 23, 2005, Pages 7418-7425

  Guan, Pingping ^a   Doytchinova, Irini A ^a   Walshe, Valerie A ^a   Borrow, Persephone ^a   Flower, Darren R ^a  

^a UK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

AMINO ACID METABOLISM; ARTICLE; BINDING AFFINITY; CLUSTER ANALYSIS; GENETIC ALGORITHM; MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE ANALYSIS; PREDICTION; PROTEIN ANALYSIS; PROTEIN BINDING; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REGRESSION ANALYSIS;

ALGORITHMS; AMINO ACIDS; HLA-A ANTIGENS; HUMANS; MODELS, MOLECULAR; OLIGOPEPTIDES; PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 28544451206     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0505258     Document Type: Article

References (64)

1. Sneath, P. H. Relations between chemical structure and biological activity in peptides. J. Theor. Biol. 1966, 12 (2), 157-195.
2. Kidera, A.; Konishi, Y.; Poka, M.; Ooi, T.; Scheraga, H. A. Statistical analysis of the physical properties of the 10 naturally occurring amino acids. J. Protein Chem. 1985, 4, 23-55.
3. Nakai, K.; Kidera, A.; Kanehisa, M. Cluster analysis of amino acid indices for prediction of protein structure and function. Protein Eng. 1988, 2 (2), 93-100.
4. Fauchere, J. L.; Charton, M.; Kier, L. B.; Verloop, A.; Pliska, V. Amino acid side chain parameters for correlation studies in biology and pharmacology. Int. J. Pept. Protein Res. 1988, 32 (4), 269-278.
5. Kawashima, S.; Kanehisa, M. AAindex: amino acid index database. Nucleic Acids Res. 2000, 28 (1), 374.
6. Collantes, E. R.; Dunn, W. J., 3rd, Amino acid side chain descriptors for quantitative structure-activity relationship studies of peptide analogues. J. Med. Chem. 1995, 38 (14), 2705-2713.
7. Norinder, U. Theoretical amino acid descriptors. Application to bradykinin potentiating peptides. Peptides 1991, 12 (6), 1223-1227.
8. Felipe-Sotelo, M.; Andrade, J. M.; Carlosena, A.; Prada, D. Partial least squares multivariate regression as an alternative to handle interferences of Fe on the determination of trace Cr in water by electrothermal atomic absorption spectrometry. Anal. Chem. 2003, 75 (19), 5254-61.
9. Hasegawa, K.; Funatsu, K. Partial least squares modeling and genetic algorithm optimization in quantitative structure-activity relationships. SAR QSAR Environ Res. 2000, 11 (3-4), 189-209.
10. Cui, M.; Huang, X.; Luo, X.; Briggs, J. M.; Ji, R.; Chen, K.; Shen, J.; Jiang, H. Molecular docking and 3D-QSAR studies on gag peptide analogue inhibitors interacting with human cyclophilin A. J. Med. Chem. 2002, 45 (24), 5249-5259.
11. Gupta, M. K.; Mishra, P.; Prathipati, P.; Saxena, A. K. 2D-QSAR in hydroxamic acid derivatives as peptide deformylase inhibitors and antibacterial agents. Bioorg. Med. Chem. 2002, 10 (12), 3713-3716.
12. Eriksson, L.; Jonsson, J.; Hellberg, S.; Lindgren, F.; Skagerberg, B.; Sjostrom, M.; Wold, S. Peptide QSAR on substance P analogues, enkephalins and bradykinins containing L- and D-amino acids. Acta Chem. Scand. 1990, 44 (1), 50-55.
13. Nadasdi, L.; Medzihradszky, K. A study of the applicability of QSAR calculation for peptide hormones. Biochem. Biophys. Res. Commun. 1981, 99 (2), 451-457.
14. Sun, H. A universal molecular descriptor system for prediction of logP, logS, logBB, and absorption. J. Chem. Inf. Comput. Sci. 2004, 44 (2), 748-757.
15. Zhao, Y.; Jona, J.; Chow, D. T.; Rong, H.; Semin, D.; Xia, X.; Zanon, R.; Spancake, C.; Maliski, E. High-throughput logP measurement using parallel liquid chromatography/ultraviolet/mass spectrometry and sample-pooling. Rapid Commun. Mass Spectrom. 2002, 16 (16), 1548-1555.
16. Xing, L.; Glen, R. C. Novel methods for the prediction of logP, pK(a), and logD. J. Chem. Inf. Comput. Sci. 2002, 42 (4), 796-805.
17. Hunt, P. A. QSAR using 2D descriptors and Tripos' SIMCA. J. Comput.-Aided Mol. Des. 1999, 13 (5), 453-467.
18. Hellberg, S.; Sjostrom, M.; Skagerberg, B.; Wold, S. Peptide quantitative structure-activity relationships, a multivariate approach. J. Med. Chem. 1987, 30 (7), 1126-1135.
19. Hellberg, S.; Eriksson, L.; Jonsson, J.; Lindgren, F.; Sjostrom, M.; Skagerberg, B.; Wold, S.; Andrews, P. Minimum analogue peptide sets (MAPS) for quantitative structure-activity relationships. Int. J. Pept. Protein Res. 1991, 37 (5), 414-424.
20. Hellberg, S.; Sjostrom, M.; Wold, S. The prediction of bradykinin potentiating potency of pentapeptides. An example of a peptide quantitative structure-activity relationship. Acta Chem. Scand. B 1986, 40 (2), 135-140.
21. Eriksson, L.; Jonsson, J.; Sjostrom, M.; Wold, S. Multivariate parametrization of coded and non-coded amino acids by thin-layer chromatography. Prog. Clin. Biol. Res. 1989, 291, 131-134.
22. Sandberg, M.; Eriksson, L.; Jonsson, J.; Sjostrom, M.; Wold, S. New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids. J. Med. Chem. 1998, 41, 2481-2491.
23. Siebert, K. J. Quantitative structure-activity relationship modeling of peptide and protein behavior as a function of amino acid composition. J. Agric. Food. Chem. 2001, 49 (2), 851-858.
24. Wanchana, S.; Yamashita, F.; Kara, H.; Fujiwara, S.; Akamatsu, M.; Hashida, M. Two- and three-dimensional QSAR of carrier-mediated transport of beta-lactam antibiotics in Caco-2 cells. J. Pharm. Sci. 2004, 93 (12), 3057-3065.
25. Bayram, E.; Santago, P., 2nd; Harris, R.; Xiao, Y. D.; Clauset, A. J.; Schmitt, J. D. Genetic algorithms and self-organizing maps: a powerful combination for modeling complex QSAR and QSPR problems. J. Comput.-Aided Mol. Des. 2004, 18 (7-9), 483-493.
26. McSparron, H.; Blythe, M. J.; Zygouri, C.; Doytchinova, I. A.; Flower, D. R. JenPep: a novel computational information resource for immunobiology and vaccinology. J. Chem. Inf. Comput. Sci. 2003, 43 (4), 1276-1287.
27. Toseland, C. P.; Taylor, D. J.; McSparron, H.; Hemsley, S. L.; Blythe, M. J.; Paine, K.; Doytchinova, I. A.; Guan, P.; Hattotuwagama, C. K.; Flower, D. R. AntiPep: a quantitative immunology database integrating functional, thermodynamic, kinetic, biophysical and cellular data. Immunome Res. 2005, 1:4.
28. Tsai, V.; Southwood, S.; Sidney, J.; Sakaguchi, K.; Kawakami, Y.; Appella, E.; Sette, A.; Celis, E. Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells. J. Immunol. 1997, 158 (4), 1796-1802.
29. Rongcun, Y.; Salazar-Onfray, F.; Charo, J.; Malmberg, K. J.; Evrin, K.; Maes, H.; Kono, K.; Hising, C.; Petersson, M.; Larsson, O.; Lan, L.; Appella, E.; Sette, A.; Celis, E.; Kiessling, R. Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas. J. Immunol. 1999, 163 (2), 1037-1044.
30. Rivoltini, L.; Kawakami, Y.; Sakaguchi, K.; Southwood, S.; Sette, A.; Robbins, P. F.; Marincola, F. M.; Salgaller, M. L.; Yannelli, J. R.; Appella, E.; et al. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol. 1995, 154 (5), 2257-2265.
31. Parkhurst, M. R.; Fitzgerald, E. B.; Southwood, S.; Sette, A.; Rosenberg, S. A.; Kawakami, Y. Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). Cancer Res. 1998, 58 (21), 4895-4901.
32. Kast, W. M.; Brandt, R. M.; Sidney, J.; Drijfhout, J. W.; Kubo, R. T.; Grey, H. M.; Melief, C. J.; Sette, A. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J. Immunol. 1994, 152 (8), 3904-3912.
33. Sette, A.; Vitiello, A.; Reherman, B.; Fowler, P.; Nayersina, R.; Kast, W. M.; Melief, C. J.; Oseroff, C.; Yuan, L.; Ruppert, J.; et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 1994, 153 (12), 5586-5592.
34. del Guercio, M. F.; Sidney, J.; Hermanson, G.; Perez, C.; Grey, H. M.; Kubo, R. T.; Sette, A. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J. Immunol. 1995, 154 (2), 685-693.
35. Vitiello, A.; Sette, A.; Yuan, L.; Farness, P.; Southwood, S.; Sidney, J.; Chesnut, R. W.; Grey, H. M.; Livingston, B. Comparison of cytotoxic T lymphocyte responses induced by peptide or DNA immunization: implications on immunogenicity and immunodominance. Eur. J. Immunol. 1997, 27 (3), 671-678.
36. Parkhurst, M. R.; Salgaller, M. L.; Southwood, S.; Robbins, P. F.; Sette, A.; Rosenberg, S. A.; Kawakami, Y. Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201- binding residues. J. Immunol. 1996, 157 (6), 2539-2548.
37. Wold, S. PLS for Multivariate Linear Modelling. In Chemometric Methods in Molecular Design; van de Waterbeemd, H., Ed.; VCH: Weinheim, Germany, 1995; pp 195-218.
38. Bush, B. L.; Nachbar, R. B., Jr. Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA. J. Comput.-Aided Mol. Des. 1993, 7 (5), 587-619.
39. Eriksson, L.; Johansson, E. Multivariate design and modeling in QSAR Chemom. Intell. Lab. Syst. 1996, 34 (1), 1-19.
40. Cruciani, G.; Watson, K. A. Comparative molecular field analysis using GRID force-field and GOLPE variable selection methods in a study of inhibitors of glycogen phosphorylase b. J. Med. Chem. 1994, 37 (16), 2589-2601.
41. MyIntyre, C.; Rees, R.; Platts, K.; Cooke, C.; Smith, M.; Mulcahy, K.; Murray, A. Identification of peptide epitopes of MAGE-1, -2, -3 that demonstrate HLA-A3-specific binding. Cancer Immunol. Immunother. 1996, 42, 246-250.
42. Salter, R.; Cresswell, P. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J. 1986, 5, 943-949.
43. Yoon, H.; Chung, M. K.; Min, S. S.; Lee, H. G.; Yoo, W. D.; Chung, K. T.; Jung, N. P.; Park, S. N. Synthetic peptides of human papillomavirus type 18 E6 harboring HLA-A2.1 motif can induce peptide-specific cytotoxic T-cells from peripheral blood mononuclear cells of healthy donors. Virus Res. 1998, 54 (1), 23-29.
44. Gairin, J. E.; Mazarguil, H.; Hudrisier, D.; Oldstone, M. B. Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes. J. Virol. 1995, 69 (4), 2297-2305.
45. Hudrisier, D.; Mazarguil, H.; Laval, F.; Oldstone, M. B. A.; Gairin, J. E. Binding of viral antigens to major histocompatibility complex class I H-2Db molecules is controlled by dominant negative elements at peptide non-anchor residues. J. Biol. Chem. 1996, 271, 17829-17836.
46. Hudrisier, D.; Mazarguil, H.; Oldstone, M. B.; Gairin, J. E. Relative implication of peptide residues in binding to major histocompatibility complex class I H-2Db: application to the design of high-affinity, allele-specific peptides. Mol. Immunol. 1995, 32 (12), 895-907.
47. Doytchinova, I. A.; Walshe, V. A.; Jones, N. A.; Gloster, S. E.; Borrow, P.; Flower, D. R. Coupling in silico and in vitro analysis of peptide-mhc binding: A bioinformatic approach enabling prediction of superbinding peptides and anchorless epitopes. J. Immunol. 2004, 172, 7495-7502.
48. Madden, D. R.; Garboczi, D. N.; Wiley, D. C. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 1993, 75, 693-708.
49. Young, A. C.; Zhang, W.; Sacchettini, J. C.; Nathenson, S. G. The three-dimensional structure of H-2Db at 2.4 Å resolution: implications for antigen-determinant selection. Cell 1994, 76 (1), 39-50.
50. Ruppert, J.; Sidney, J.; Celis, E.; Kubo, R. T.; Grey, H. M.; Sette, A. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 1993, 74 (5), 929-937.
51. Rammensee, H. G.; Friede, T.; Stevanoviic, S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995, 41 (4), 178-228.
52. Falk, K.; Rotzschke, O. Consensus motifs and peptide ligands of MHC class I molecules. Semin. Immunol. 1993, 5 (2), 81-94.
53. Drijfhout, J. W.; Brandt, R. M.; D'Amaro, J.; Kast, W. M.; Melief, C. J. Detailed motifs for peptide binding to HLA-A*0201 derived from large random sets of peptides using a cellular binding assay. Hum. Immunol. 1995, 43 (1), 1-12.
54. Falk, K.; Rotzschke, O.; Stevanovic, S.; Jung, G.; Rammensee, H. G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991, 351 (6324), 290-296.
55. Doytchinova, I.; Flower, D. The HLA-A2-supermotif: a QSAR definition. Org. Biomol. Chem. 2003, 1 (15), 2648-2654.
56. Doytchinova, I. A.; Blythe, M. J.; Flower, D. R. Additive method for the prediction of protein-peptide binding affinity. Application to the MHC class I molecule HLA-A*0201. J. Proteome Res. 2002, 1 (3), 263-272.
57. Doytchinova, I. A.; Flower, D. R. A comparative molecular similarity index analysis (CoMSIA) study identifies an HLA-A2 binding supermotif. J. Comput.-Aided Mol. Des. 2002, 16 (8-9), 535-544.
58. Guan, P.; Doytchinova, I. A.; Flower, D. R. A comparative molecular similarity indices (CoMSIA) study of peptide binding to the HLA-A3 superfamily. Bioorg. Med. Chem. 2003, 11 (10), 2307-2311.
59. Guan, P.; Doytchinova, I. A.; Flower, D. R. HLA-A3 supermotif defined by quantitative structure-activity relationship analysis. Protein Eng. 2003, 16 (1), 11-18.
60. Hattotuwagama, C. K.; Guan, P.; Doytchinova, I. A.; Flower, D. R. New horizons in mouse immunoinformatics: reliable in silico prediction of mouse class I histocompatibility major complex peptide binding affinity. Org. Biomol. Chem. 2004, 2 (22), 3274-3283.
61. McAdam, S. N.; Fleckenstein, B.; Rasmussen, I. B.; Schmid, D. G.; Sandlie, I.; Bogen, B.; Viner, N. J.; Sollid, L. M. T cell recognition of the dominant I-A(k)-restricted hen egg lysozyme epitope: critical role for asparagine deamidation. J. Exp. Med. 2001, 193 (11), 1239-1246.
62. Hill, J. A.; Southwood, S.; Sette, A.; Jevnikar, A. M.; Bell, D. A.; Cairns, E. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J. Immunol. 2003, 171 (2), 538-541.
63. Andersen, M. H.; Bonfill, J. E.; Neisig, A.; Arsequell, G.; Sondergaard, I.; Valencia, G.; Neefjes, J.; Zeuthen, J.; Elliott, T.; Haurum, J. S. Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL. J. Immunol. 1999, 163 (7), 3812-3818.
64. Holm, L.; Kjellen, P.; Holmdahl, R.; Kihlberg, J. Identification of the minimal glycopeptide core recognized by T cells in a model for rheumatoid arthritis. Bioorg. Med. Chem. 2005, 13 (2), 473-482.